Cell & Gene Therapy for Cancer
Part of Healthcare - Oncology
 GILD | Gilead Sciences Inc | $166.9b | $127.40 | +2.8% | 7.2M |
 ACLX | Arcellx, Inc. Common Stock | $6.7b | $115.06 | -0.0% | 16.1M |
 NTLA | Intellia Therapeutics, Inc | $2.0b | $16.63 | +3.9% | 4.4M |
 IOVA | Iovance Biotherapeutics, Inc. Common Stock | $1.8b | $4.24 | +0.4% | 10.9M |
 IMTX | Immatics N.V. Ordinary Shares | $1.6b | $9.53 | +0.2% | 207.1K |
 SANA | Sana Biotechnology, Inc. Common Stock | $0.9b | $3.44 | +4.6% | 3.1M |
 VOR | Vor Biopharma Inc. Common Stock | $0.8b | $15.55 | +8.6% | 1.9M |
 ALLO | Allogene Therapeutics, Inc. Common Stock | $0.7b | $2.13 | +2.9% | 7.6M |
 IMMX | Immix Biopharma, Inc. Common Stock | $0.6b | $9.97 | +2.6% | 1.5M |
 IPSC | Century Therapeutics, Inc. Common Stock | $441.9m | $2.38 | +1.7% | 2.2M |
 LYEL | Lyell Immunopharma, Inc. Common Stock | $404.4m | $11.91 | -5.8% | 232.0K |
 ARTV | Artiva Biotherapeutics, Inc. Common Stock | $385.3m | $9.14 | +8.8% | 317.7K |
 FATE | Fate Therapeutics, Inc. | $331.0m | $2.10 | +12.0% | 3.9M |
 TARA | Protara Therapeutics, Inc. Common Stock | $267.5m | $4.15 | +2.8% | 829.2K |
 CRBU | Caribou Biosciences, Inc. Common Stock | $234.1m | $1.67 | +6.4% | 2.0M |
 NKTX | Nkarta, Inc. Common Stock | $232.5m | $2.79 | +1.1% | 719.0K |
 YDES | YD Bio Limited Ordinary Shares | $228.1m | $2.34 | 0.0% | 15.4K |
 ENGN | enGene Therapeutics Inc. Common Stock | $123.9m | $1.75 | -1.1% | 1.2M |
 ATRA | Atara Biotherapeutics, Inc | $94.7m | $10.47 | -0.1% | 34.0K |
 ANIX | Anixa Biosciences, Inc. | $90.5m | $2.86 | +5.5% | 988.9K |
 ACET | Adicet Bio, Inc. Common Stock | $87.0m | $8.32 | +5.4% | 72.4K |
 TCRX | TScan Therapeutics, Inc. Common Stock | $70.6m | $0.91 | +14.7% | 651.5K |
 COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $66.7m | $16.39 | -0.1% | 105.9K |
 INKT | MiNK Therapeutics, Inc. Common Stock | $60.8m | $12.30 | +0.8% | 25.6K |
 ESLA | Estrella Immunopharma, Inc. Common Stock | $46.9m | $0.95 | 0.0% | 36.3K |
 TVGN | Tevogen Bio Holdings Inc. Common Stock | $33.1m | $7.42 | -4.5% | 12.5K |
 SNTI | Senti Biosciences Holdings, Inc. Common Stock | $29.6m | $1.07 | +3.3% | 159.3K |
 CELU | Celularity Inc. Class A Common Stock | $29.2m | $0.69 | -5.4% | 176.9K |
 INAB | IN8bio, Inc. Common Stock | $18.4m | $1.38 | +0.7% | 43.2K |
 LNAI | Lunai Bioworks Inc. Common Stock | $14.0m | $3.25 | -9.8% | 143.7K |
 GDTC | CytoMed Therapeutics Limited Ordinary Shares | $13.8m | $0.98 | 0.0% | 56.8K |
 ERNA | Ernexa Therapeutics Inc. Common Stock | $12.3m | $6.83 | -8.8% | 80.6K |
 PMCB | PharmaCyte Biotech, Inc. Common Stock | $9.0m | $0.76 | 0.0% | 32.5K |
 MBIO | Mustang Bio, Inc. | $5.1m | $0.71 | 0.0% | 43.1K |
 CLDI | Calidi Biotherapeutics, Inc. | $3.6m | $0.16 | +6.9% | 17.2M |